Clinical Trial

Reduced Vaccine Response to HZ/su in SLE

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to compare the vaccine response to the 2 doses of the adjuvanted herpes zoster subunit vaccine(HZ/su, "Shingrix") in patients with SLE and the age-, sex-, ethnicity-matched controls without autoimmune disease.
Trial Details
NCT Number NCT07636044
Lead Sponsor Seoul National University Hospital
Conditions Vaccine Reaction, Zoster, Systemic Lupus Erythematosus
Enrollment 80 participants
Start Date 2024-10-01
Primary Completion 2030-10-01 (estimated)
Study Completion 2030-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-09